Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-03-01

Clinical Trial Update: Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating albumin dialysis in end-stage renal disease to assess detoxification capacity and effects on vascular endothelial function, with th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Chronic Kidney Disease | Phase 1, Phase 2 | Status: SUSPENDED